OIG: Requirements for determining AMPs unclear
Pharma Compliance Alert, June 7, 2006
The OIG recently studied the requirements for how manufacturers determine average manufacturer prices (AMP) for prescription drugs and found them to be unclear. The OIG also found inconsistencies in the ways manufacturers calculate AMPs, it reports.
The OIG recommended that CMS take several steps to improve the process, such as clarifying certain requirements and issuing new guidance that specifically addresses AMP-related reimbursement.
Beginning July 1, HHS must supply AMP data to states every month, and states may choose to use the AMP data in setting reimbursement amounts. However, errors or inconsistencies in AMP calculations could lead to inaccurate reimbursements and rebate errors.
Click here to read the entire OIG report.
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- Capturing all necessary codes for IUD insertion and removal can be challenging
- QA:Coding multiple initial infusions
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q&A tackles coding questions about injections and infusions
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- Case Management Monthly, June 2012
- Searched